April 28 2021
We are pleased to invite you to this exclusive webinar where we present the results of a proof of concept study done on our staining platform: LabSat®.
The RNAscope™ assay, based on ACD’s technology for signal amplification and background suppression, was optimized on LabSat® to result in well-preserved morphology, uniform staining with excellent signal-to-noise ratio, and readily detectable punctate signal dots – comparable to the manual assay on the mouse and human FFPE samples. Concomitantly, the assay turnaround time was shortened concerning the manual and other automated CISH protocols. Overall, we have proven the capability of the microfluidic platform LabSat® to automate the RNAscope™2.5 HD-BROWN CISH assay with reproducible staining results. The microfluidic platform brings the benefits of a shorter run time and reliability of a compact desktop system.
April 28, 2021
- Lunaphore’s patented microfluidic staining technology & the LabSat® Instrument
- RNAscope™ technology and general workflow
- Conclusions and Outlooks
Project Manager Scientific Affairs